StockClub

SBHMY

SBHMYSino Biopharmaceutical Limited$ --
Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited

SBHMY

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 06/30/2025FY2025 Q2
Revenue
8,787M CNY
YoY +10.7%
Operating Income
1,881M CNY
YoY +4.4%
Net Income
1,694M CNY
YoY +12.3%
EPS
1.88CNY
YoY +144.2%

Revenue

CNY17.6B
FY2023 Q1CNY7.6B
CNY7.6B
Q1
FY2023 Q2CNY15.3B
CNY15.3B
Q2
FY2024 Q1CNY7.9B
CNY7.9B
Q1
FY2024 Q2CNY15.9B
CNY15.9B
Q2
FY2024 Q3CNY22.4B
CNY22.4B
Q3
FY2024 Q4CNY28.9B
CNY28.9B
Q4
FY2025 Q1CNY8.8B
CNY8.8B
Q1
FY2025 Q2CNY17.6B
CNY17.6B
Q2
Actual
+CNY1.7B (+10.7%)

Net Income

CNY3.4B
FY2023 Q1CNY629.4M
CNY629.4M
Q1
FY2023 Q2CNY1.3B
CNY1.3B
Q2
FY2024 Q1CNY1.5B
CNY1.5B
Q1
FY2024 Q2CNY3B
CNY3B
Q2
FY2024 Q3CNY3.3B
CNY3.3B
Q3
FY2024 Q4CNY3.5B
CNY3.5B
Q4
FY2025 Q1CNY1.7B
CNY1.7B
Q1
FY2025 Q2CNY3.4B
CNY3.4B
Q2
Actual
+CNY371.4M (+12.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:CNY24.2B
FY2019
CNY24.2B
FY2020
Actual:CNY23.6B
FY2020
CNY23.6B
FY2021
Actual:CNY26.9B
FY2021
CNY26.9B
FY2022
Actual:CNY26B
FY2022
CNY26B
FY2023
Actual:CNY26.2B
FY2023
CNY26.2B
FY2024MISS
Actual:CNY28.9B
Est:CNY214.5B
FY2024MISS
CNY28.9B

Analyst Estimates